(function(e){function t(t){for(var n,s,o=t[0],l=t[1],c=t[2],u=0,p=[];u<o.length;u++)s=o[u],Object.prototype.hasOwnProperty.call(i,s)&&i[s]&&p.push(i[s][0]),i[s]=0;for(n in l)Object.prototype.hasOwnProperty.call(l,n)&&(e[n]=l[n]);d&&d(t);while(p.length)p.shift()();return r.push.apply(r,c||[]),a()}function a(){for(var e,t=0;t<r.length;t++){for(var a=r[t],n=!0,o=1;o<a.length;o++){var l=a[o];0!==i[l]&&(n=!1)}n&&(r.splice(t--,1),e=s(s.s=a[0]))}return e}var n={},i={app:0},r=[];function s(t){if(n[t])return n[t].exports;var a=n[t]={i:t,l:!1,exports:{}};return e[t].call(a.exports,a,a.exports,s),a.l=!0,a.exports}s.m=e,s.c=n,s.d=function(e,t,a){s.o(e,t)||Object.defineProperty(e,t,{enumerable:!0,get:a})},s.r=function(e){"undefined"!==typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},s.t=function(e,t){if(1&t&&(e=s(e)),8&t)return e;if(4&t&&"object"===typeof e&&e&&e.__esModule)return e;var a=Object.create(null);if(s.r(a),Object.defineProperty(a,"default",{enumerable:!0,value:e}),2&t&&"string"!=typeof e)for(var n in e)s.d(a,n,function(t){return e[t]}.bind(null,n));return a},s.n=function(e){var t=e&&e.__esModule?function(){return e["default"]}:function(){return e};return s.d(t,"a",t),t},s.o=function(e,t){return Object.prototype.hasOwnProperty.call(e,t)},s.p="/";var o=window["webpackJsonp"]=window["webpackJsonp"]||[],l=o.push.bind(o);o.push=t,o=o.slice();for(var c=0;c<o.length;c++)t(o[c]);var d=l;r.push([0,"chunk-vendors"]),a()})({0:function(e,t,a){e.exports=a("56d7")},"034f":function(e,t,a){"use strict";a("85ec")},"56d7":function(e,t,a){"use strict";a.r(t);a("e260"),a("e6cf"),a("cca6"),a("a79d");var n=a("2b0e"),i=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("div",{staticStyle:{"max-width":"500px",margin:"0 auto"},attrs:{id:"app mx-auto"}},[1===e.page?a("div",[a("Header"),a("div",{staticClass:"m-3",staticStyle:{color:"#000","padding-top":"80px",display:"flex","justify-content":"space-between"}},[a("h4",[e._v("All Users")]),a("div",{class:e.enableSelect?"is-selecting":"not-selecting",on:{click:function(t){e.enableSelect=!e.enableSelect}}},[e._v(" Select ")])]),a("div",[a("b-form-checkbox-group",{attrs:{id:"checkbox-group-2",name:"flavour-2"},model:{value:e.selectedUsers,callback:function(t){e.selectedUsers=t},expression:"selectedUsers"}},e._l(e.users,(function(t,n){return a("div",{key:"user_"+n,staticClass:"user-in-list",on:{click:function(a){return e.gotoPage(t)}}},[a("div",[a("div",{staticStyle:{flex:"1"}},[t.profilePic?a("img",{staticStyle:{width:"100px","border-radius":"100px"},attrs:{src:t.profilePic}}):a("div",{staticStyle:{width:"100px",height:"100px",display:"flex","align-items":"center","justify-content":"center","border-radius":"100px",background:"#f2f2f2",color:"#bdbdbd","font-size":"30px"}},[e._v(" "+e._s(e.uimg(t.name))+" ")])])]),a("div",{staticStyle:{flex:"2","align-items":"left",display:"flex","flex-direction":"column","padding-left":"20px","justify-content":"center"}},[a("div",{staticStyle:{"font-size":"20px"}},[e._v(e._s(t.name))]),a("div",[e._v(e._s(t.diseases))])]),a("div",{staticStyle:{flex:"1","align-items":"left",display:"flex","flex-direction":"column","padding-left":"20px","justify-content":"center"}},[e._v(" "+e._s(t.age)+" "+e._s(t.gender)+" ")]),a("div",{staticStyle:{width:"20px","align-items":"left",display:"flex","flex-direction":"column","justify-content":"center"}},[e.enableSelect?a("div",[a("b-form-checkbox",{attrs:{value:t.id},on:{click:e.selectUser}})],1):e._e()])])})),0)],1),e.enableSelect&&e.selectedUsers.length>0?a("Footer"):e._e()],1):2===e.page?a("div",[a("HeaderPage2",{attrs:{user:e.viewUser},on:{gotoPage:e.goBackToPage}}),a("div",{staticStyle:{color:"#000","padding-top":"80px",display:"flex","flex-wrap":"wrap"}},e._l(e.filters,(function(t,n){return a("div",{key:"fil_"+n,staticClass:"filter"},[e._v(" "+e._s(t)+" ")])})),0),a("div",{staticStyle:{padding:"20px 10px"}},[e.viewUser.medication?a("div",[a("h4",[e._v("Medication")]),e._l(e.viewUser.medication,(function(t,n){return a("div",{key:"med_"+n},[e._v(" "+e._s(t.StartDate)+" "+e._s(t.EndDate)+" "+e._s(t.Medicine)+" ")])}))],2):e._e(),e.viewUser.labs?a("div",[a("h4",[e._v("Labs")]),e._l(e.viewUser.labs,(function(t,n){return a("div",{key:"lab_"+n,staticClass:"lab-info"},[a("div",{staticClass:"med-labname"},[e._v(e._s(t.labName))]),a("div",[e._v(e._s(t.labData))])])}))],2):e._e()]),a("button",{on:{click:e.insertUserInSheet}},[e._v("Insert User")])],1):e._e()])},r=[],s=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("b-navbar",{staticClass:"p-2",staticStyle:{"background-color":"#fff !important"},attrs:{type:"light",fixed:"top"}},[a("Sidebar",{staticStyle:{position:"absolute",left:"26px"}}),a("b-form-input",{staticClass:"m-1 nav-shadow ",staticStyle:{padding:"13px 40px"},attrs:{placeholder:"Search Profiles"},model:{value:e.search,callback:function(t){e.search=t},expression:"search"}}),e.isSearched?a("div",{staticStyle:{position:"absolute",right:"30px"},on:{click:function(t){e.search=""}}},[a("svg",{attrs:{width:"24",height:"24",viewBox:"0 0 24 24",fill:"none",xmlns:"http://www.w3.org/2000/svg"}},[a("path",{attrs:{"fill-rule":"evenodd","clip-rule":"evenodd",d:"M19 6.41L17.59 5L12 10.59L6.41 5L5 6.41L10.59 12L5 17.59L6.41 19L12 13.41L17.59 19L19 17.59L13.41 12L19 6.41Z",fill:"#5F6368"}})])]):e._e(),""===e.search||e.isSearched?e._e():a("div",{staticStyle:{position:"absolute",right:"30px"},on:{click:e.searchUser}},[a("svg",{attrs:{width:"16",height:"17",viewBox:"0 0 16 17",fill:"none",xmlns:"http://www.w3.org/2000/svg"}},[a("path",{attrs:{d:"M15.875 14.6562L12.0938 10.875C12 10.8125 11.9062 10.75 11.8125 10.75H11.4062C12.375 9.625 13 8.125 13 6.5C13 2.9375 10.0625 0 6.5 0C2.90625 0 0 2.9375 0 6.5C0 10.0938 2.90625 13 6.5 13C8.125 13 9.59375 12.4062 10.75 11.4375V11.8438C10.75 11.9375 10.7812 12.0312 10.8438 12.125L14.625 15.9062C14.7812 16.0625 15.0312 16.0625 15.1562 15.9062L15.875 15.1875C16.0312 15.0625 16.0312 14.8125 15.875 14.6562ZM6.5 11.5C3.71875 11.5 1.5 9.28125 1.5 6.5C1.5 3.75 3.71875 1.5 6.5 1.5C9.25 1.5 11.5 3.75 11.5 6.5C11.5 9.28125 9.25 11.5 6.5 11.5Z",fill:"#4A4A4A"}})])])],1)},o=[],l=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("div",{staticStyle:{"font-size":"20px"}},[a("div",{directives:[{name:"b-toggle",rawName:"v-b-toggle.sidebar-variant",modifiers:{"sidebar-variant":!0}}],staticStyle:{border:"none"},attrs:{variant:"outline-secondary"}},[a("b-icon",{attrs:{icon:"list"}})],1),a("b-sidebar",{attrs:{id:"sidebar-variant",title:"Sidebar","bg-variant":"light","text-variant":"dark",shadow:""}},[a("div",{staticClass:"px-3 py-2"},[a("p")])])],1)},c=[],d=a("2877"),u={},p=Object(d["a"])(u,l,c,!1,null,null,null),E=p.exports,f={name:"Header",components:{Sidebar:E},data:function(){return{uuid:"",search:"",isSearched:!1}},created:function(){},methods:{searchUser:function(){}}},b=f,m=Object(d["a"])(b,s,o,!1,null,null,null),R=m.exports,g=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("b-navbar",{staticClass:"nav-shadow",staticStyle:{"background-color":"#fff !important"},attrs:{type:"light",fixed:"top"}},[a("b-button",{staticClass:"my-2 my-sm-0 mr-2",attrs:{variant:"transparent"},on:{click:e.back}},[a("BackIcon")],1),e._v(" "+e._s(e.user.name)+" ")],1)},v=[],h=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("svg",{attrs:{width:"18",height:"12",viewBox:"0 0 18 12",fill:"none",xmlns:"http://www.w3.org/2000/svg"}},[a("path",{attrs:{d:"M18 5H3.83L7.41 1.41L6 0L0 6L6 12L7.41 10.59L3.83 7H18V5Z",fill:"#C6C2C2"}})])},x=[],D={},B=D,S=Object(d["a"])(B,h,x,!1,null,null,null),H=S.exports,P={name:"HeaderPage2",props:["user"],components:{BackIcon:H},methods:{back:function(){this.$emit("gotoPage",1)}}},w=P,C=Object(d["a"])(w,g,v,!1,null,null,null),y=C.exports,M=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("b-navbar",{staticClass:"nav-footer-shadow",staticStyle:{display:"flex","justify-content":"center"},attrs:{shadow:"",variant:"light",type:"light",fixed:"bottom"}},[a("b-button",{attrs:{variant:"light"}},[a("AppleUploadIcon"),a("span",{staticStyle:{"margin-left":"10px"}},[e._v("View in Sheets")])],1)],1)},_=[],k=function(){var e=this,t=e.$createElement,a=e._self._c||t;return a("svg",{attrs:{width:"19",height:"18",viewBox:"0 0 19 18",fill:"none",xmlns:"http://www.w3.org/2000/svg","xmlns:xlink":"http://www.w3.org/1999/xlink"}},[a("rect",{attrs:{y:"18",width:"18",height:"19",transform:"rotate(-90 0 18)",fill:"url(#pattern0)"}}),a("defs",[a("pattern",{attrs:{id:"pattern0",patternContentUnits:"objectBoundingBox",width:"1",height:"1"}},[a("use",{attrs:{"xlink:href":"#image0",transform:"translate(0 0.0263158) scale(0.0416667 0.0394737)"}})]),a("image",{attrs:{id:"image0",width:"24",height:"24","xlink:href":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABgAAAAYCAYAAADgdz34AAAAs0lEQVRIS+2VwQ2DQAwEhx9FkNRDJamBH3zTQtII9ZBCQJYOyVLMsSfBAwl+gL2zWMe64uSrOlmfUsAA1ECnGisBmHifhN8qRAV48dW8BFEAkbgMUQB+3HO6kfuiwhb4Ag38HYItgD3/AS9g9I4iwAQ8NpzmANZikOceIDeG4nfRFxSLJMdh3w3YPcL3iK43otwaOOQ/OATgs0hdXGudlEWWph8XeCpETlNVUKqTF4ekFhQtWP41GUyN2LsAAAAASUVORK5CYII="}})])])},A=[],U={},N=U,O=Object(d["a"])(N,k,A,!1,null,null,null),z=O.exports,L={components:{AppleUploadIcon:z}},j=L,G=Object(d["a"])(j,M,_,!1,null,null,null),T=G.exports,F={name:"App",components:{Header:R,Footer:T,HeaderPage2:y},data:function(){return{page:1,enableSelect:!1,viewUser:"",users:[{id:1,profilePic:"https://dailybits.xyz/images/he.png",name:"Tania Sethi",age:52,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:2,profilePic:"",name:"Marilyn Harms",age:54,gender:"M",diseases:"Cholangiocarcinoma",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:3,profilePic:"",name:"Sandra Mitchell",age:49,gender:"F",diseases:"Cholangiocarcinoma",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,profilePic:"",name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,profilePic:"",name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,profilePic:"",name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,profilePic:"",name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,profilePic:"",name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,profilePic:"",name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]},{id:4,profilePic:"",name:"Gina Offutt",age:34,gender:"F",diseases:"Breast Cancer",selected:!1,medication:[{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Docetaxel"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Carboplatin"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Trastuzumab"},{StartDate:"7/27/20",EndDate:"7/27/20",Medicine:"Pertuzumab Regimen"}],labs:[{labName:"Unknown lab name, 4/15/20",labData:["* : HR+/HER2+ (Breast Cancer), HR+/HER2- (Breast Cancer), HR+/HER2+ (Breast Cancer)"]},{labName:"Unknown lab name, 4/15/20",labData:["* Negative for Protein Expression: HER2 (ERBB2) * Positive for Protein Expression: PR (PGR), HER2 (ERBB2), ER  (ESR1) * Equivocal Protein Expression: HER2 (ERBB2) * Alteration Present: MSH3"]}]}],filters:["medication","labs","diagnosis","procedure","vitals","allergies"],selectedUsers:[]}},methods:{insertUserInSheet:function(){try{void 0!==google&&google.script.run.insertProfile()}catch(e){console.log("error",e)}},selectUser:function(e){console.log(e),alert("user selected")},gotoPage:function(e){0!==this.selectedUsers.length||this.enableSelect||(this.viewUser=e,this.page=2)},goBackToPage:function(e){this.page=e},uimg:function(e){return e.charAt(0).toUpperCase()}}},I=F,q=(a("034f"),Object(d["a"])(I,i,r,!1,null,null,null)),V=q.exports,Q=a("5f5b"),$=a("b1e0"),Y=(a("f9e3"),a("2dd8"),a("2f62"));n["default"].use(Y["a"]);var Z=new Y["a"].Store({state:{},mutations:{},actions:{},modules:{}});n["default"].config.productionTip=!1,n["default"].use(Q["a"]),n["default"].use($["a"]),new n["default"]({store:Z,render:function(e){return e(V)}}).$mount("#app")},"85ec":function(e,t,a){}});
//# sourceMappingURL=app.d2ce896f.js.map